Brimonidine tartrate and Nitrostat drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Brimonidine tartrate (brimonidine tartrate) and Nitrostat (nitroglycerin). Common drug interactions include renal impairment among females and cerebral arteriosclerosis among males.

The phase IV clinical study analyzes what interactions people have when they take Brimonidine tartrate and Nitrostat. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Brimonidine tartrate?

Brimonidine tartrate has active ingredients of brimonidine tartrate. It is often used in glaucoma. eHealthMe is studying from 3,211 Brimonidine tartrate users. Check the latest studies of Brimonidine tartrate.

What is Nitrostat?

Nitrostat has active ingredients of nitroglycerin. It is often used in chest pain. eHealthMe is studying from 14,082 Nitrostat users. Check the latest studies of Nitrostat.

On Jul, 16, 2026

25 people who take Brimonidine tartrate and Nitrostat together, and have interactions are studied.

Brimonidine tartrate and Nitrostat drug interactions.

What are the common drug interactions of Brimonidine Tartrate and Nitrostat, by gender? *:

female:

Renal impairment (severely reduced kidney function)
Cardiac failure
Erythema (redness of the skin)
Pruritus (severe itching of the skin)
Rash
Skin burning sensation
Urine calcium increased
Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
Colon cancer
Depression

male:

Cerebral arteriosclerosis (thickening and hardening of the walls of the arteries in the brain)
Bacteria urine identified
Blood urine present
Cardiac failure
Cerebrovascular disorder (disease of brain)
Confusional state
Death
Depressed level of consciousness
Drooling (drop saliva uncontrollably from the mouth)
Leukoencephalopathy (disease of the white matter in the brain)

What are the common drug interactions of Brimonidine Tartrate and Nitrostat, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Renal impairment (severely reduced kidney function)
Cardiac failure
Hyperlipidaemia (presence of excess lipids in the blood)
Obstructive airways disorder (a progressive disease that makes it hard to breathe)
Type 1 diabetes mellitus
Urinary tract infection
Arrhythmia (irregular heartbeat)
Atrioventricular block (heart block)
Bradycardia (abnormally slow heart action)
Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)

What are the existing conditions these people have? *

Pain: 7 people, 28.00%
Hyperlipidaemia (presence of excess lipids in the blood): 7 people, 28.00%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 7 people, 28.00%
Cardiac Failure Chronic: 7 people, 28.00%
Cardiac Failure Acute: 7 people, 28.00%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 7 people, 28.00%
Lung Cancer - Non-Small Cell (lung cancer): 4 people, 16.00%
Constipation: 4 people, 16.00%
Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 3 people, 12.00%
Menopause (end of monthly cycles in women): 3 people, 12.00%

* Approximation only. Some reports may have incomplete information.

Do you take Brimonidine tartrate and Nitrostat?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously